EUVIMEDEUVIMED entdecken
Crossref

tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5

Yuanjian Shi, Zehao Pan, Yipeng Feng, Qinyao Zhou, Qinglin Wang, Hui Wang, Gaochao Dong, Wenjie Xia, Feng Jiang iD

Carcinogenesis · 10.06.2024 · 45 (6) · 409-423

DOI: 10.1093/carcin/bgae010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, online erschienen am 15.02.2024. Verfasst von Yuanjian Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Resear…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Polypyrimidine Tract-Binding Protein, Amino Acid Transport System ASC, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Medical Key Laboratory, Jiangsu Provincial Medical Innovation Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent decades, considerable evidence has emerged indicating the involvement of tRNA-derived fragments (tRFs) in cancer progression through various mechanisms. However, the biological effects and mechanisms of tRFs in lung adenocarcinoma (LUAD) remain unclear. In this study, we screen out tRF-29-79, a 5ʹ-tRF derived from tRNAGlyGCC, through profiling the tRF expressions in three pairs of LUAD tissues. We show that tRF-29-79 is downregulated in LUAD and downregulation of tRF-29-79 is associated with poorer prognosis. In vivo and in vitro assay reveal that tRF-29-79 inhibits proliferation, migration and invasion of LUAD cells. Mechanistically, we discovered that tRF-29-79 interacts with the RNA-binding protein PTBP1 and facilitates the transportation of PTBP1 from nucleus to cytoplasm, which regulates alternative splicing in the 3ʹ untranslated region (UTR) of SLC1A5 pre-mRNA. Given that SLC1A5 is a core transporter of glutamine, we proved that tRF-29-79 mediate glutamine metabolism of LUAD through affecting the stability of SLC1A5 mRNA, thus exerts its anticancer function. In summary, our findings uncover the novel mechanism that tRF-29-79 participates in glutamine metabolism through interacting with PTBP1 and regulating alternative splicing in the 3ʹ UTR of SLC1A5 pre-mRNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungPolypyrimidine Tract-Binding ProteinAmino Acid Transport System ASCLung NeoplasmsCell ProliferationHeterogeneous-Nuclear RibonucleoproteinsGene Expression Regulation, NeoplasticDisease ProgressionHumansMiceAnimalsMinor Histocompatibility AntigensCell MovementPrognosisCell Line, TumorAlternative SplicingFemaleGlutamineMale

Substanzen

Polypyrimidine Tract-Binding ProteinAmino Acid Transport System ASCSLC1A5 protein, humanPTBP1 protein, humanHeterogeneous-Nuclear RibonucleoproteinsMinor Histocompatibility AntigensGlutamine

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, 42 Baiziting Road, Xuanwu District, Nanjing 210009, China.
  • Jiangsu Key Laboratory of Molecular and Translational Cancer Research, 42 Baiziting Road, Xuanwu District, Nanjing 210009, China.
  • The Fourth Clinical College of Nanjing Medical University, Nanjing, China.
  • The First Clinical College of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Feng Jiang

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Medical Key Laboratory
  • Jiangsu Provincial Medical Innovation Center

Zitieren

APA

Shi, Y., Pan, Z., Feng, Y., Zhou, Q., Wang, Q., Wang, H., Dong, G., Xia, W., & Jiang, F. (2024). tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5. Carcinogenesis, 45(6), 409-423. https://doi.org/10.1093/carcin/bgae010

Vancouver

Shi Y, Pan Z, Feng Y, Zhou Q, Wang Q, Wang H, et al. tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5. Carcinogenesis. 2024;45(6):409-423. doi:10.1093/carcin/bgae010

BibTeX
@article{Shi2024,
  author = {Shi, Yuanjian and Pan, Zehao and Feng, Yipeng and Zhou, Qinyao and Wang, Qinglin and Wang, Hui and Dong, Gaochao and Xia, Wenjie and Jiang, Feng},
  title = {tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5},
  journal = {Carcinogenesis},
  year = {2024},
  volume = {45},
  number = {6},
  pages = {409--423},
  doi = {10.1093/carcin/bgae010}
}
Kostenlos starten →